Spectral AI

DeepView Device Will Catalyze Personalized Remote Diagnostic Care

AnalystHighTarget

Not Invested

Consensus Narrative from 5 Analysts

Published

27 Aug 25

AnalystHighTarget's Fair Value

US$7.45

74.8% undervalued

27 Aug

US$1.88

33.3%

-10.5%

33.3%

-10.5%

Edit anytime before Aug 27 9:35 PM. Then post Updates to your followers.

Author's Valuation

US$7.5

74.8% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

US$7.5

74.8% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

16.64%

Medical Equipment revenue growth rate

0.44%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.88%

Calculation

US$50.90m

Earnings '28

10.79x

PE Ratio '28

US$549.02m

Market Cap '28

US$549.02m

Market Cap '28

58.73m

No. shares '28

US$9.35

Share Price '28

US$9.35 Share Price '28

Discounted to 2025 @ 7.86% p.a.

US$7.45

Fair Value '25